CSBR:NASDAQ
Champions Oncology Inc
4,70 US$
arrow_upward
+1,18%(+0,055) 1D
13 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,57 US$
High
4,70 US$
Low
4,52 US$
Mkt. cap
65,49 მლნ.
Avg. vol.
8,16 ათ.
Volume
3,02 ათ.
52-wk high
8,31 US$
52-wk low
4,52 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,57 US$
High
4,70 US$
Low
4,52 US$
Mkt. cap
65,49 მლნ.
Avg. vol.
8,16 ათ.
Volume
3,02 ათ.
52-wk high
8,31 US$
52-wk low
4,52 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
Yahoo Finance
·
43 წუთის წინ
Nvidia Volatility Puts Nasdaq Stock And Trading Platforms In Focus
Foreign Policy Journal
·
1 საათის წინ
Rocket Lab (NASDAQ: RKLB) Carries A 1,111x Forward Multiple With Its Most Important Rocket Still Unflown
The Motley Fool
·
1 საათის წინ
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Bloomberg.com
·
1 დღის წინ
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com